Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1106)
Surrozen, Inc./DE (SRZN)
Li Yang — Exec. Vice President, Research
Shares
1,584
Price
$33.33
Total Value
$52.80K
Shares Held After
17,216
% of Holdings
8.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
172
Price
$157.49
Total Value
$27.09K
Shares Held After
2,666
% of Holdings
6.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
235
Price
$156.57
Total Value
$36.79K
Shares Held After
2,838
% of Holdings
7.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
325
Price
$155.21
Total Value
$50.44K
Shares Held After
3,073
% of Holdings
9.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
236
Price
$154.24
Total Value
$36.40K
Shares Held After
3,398
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
32
Price
$153.50
Total Value
$4.91K
Shares Held After
3,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$582.29
Total Value
$232.92K
Shares Held After
18,876
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$581.28
Total Value
$302.27K
Shares Held After
19,276
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$580.26
Total Value
$255.31K
Shares Held After
19,796
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,160
Price
$579.13
Total Value
$671.79K
Shares Held After
20,236
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
719
Price
$577.54
Total Value
$415.25K
Shares Held After
21,396
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,005
Price
$576.66
Total Value
$1.73M
Shares Held After
22,115
% of Holdings
12.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,436
Price
$575.75
Total Value
$1.40M
Shares Held After
25,120
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
487
Price
$574.84
Total Value
$279.95K
Shares Held After
27,556
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
153
Price
$573.82
Total Value
$87.79K
Shares Held After
28,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$572.40
Total Value
$274.75K
Shares Held After
28,196
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$571.00
Total Value
$22.84K
Shares Held After
28,676
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.06
Total Value
$45.60K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.60
Total Value
$45.49K
Shares Held After
28,796
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$582.29
Total Value
$139.75K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$581.78
Total Value
$233.29K
Shares Held After
40,753
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$580.98
Total Value
$325.35K
Shares Held After
41,154
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,104
Price
$579.27
Total Value
$639.52K
Shares Held After
41,714
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$578.58
Total Value
$92.57K
Shares Held After
42,818
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,039
Price
$577.26
Total Value
$599.77K
Shares Held After
42,978
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,677
Price
$576.39
Total Value
$2.12M
Shares Held After
44,017
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$575.45
Total Value
$759.60K
Shares Held After
47,694
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$574.37
Total Value
$206.20K
Shares Held After
49,014
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$572.42
Total Value
$251.86K
Shares Held After
49,373
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$570.99
Total Value
$22.84K
Shares Held After
49,813
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$569.64
Total Value
$68.36K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$568.36
Total Value
$22.73K
Shares Held After
49,973
% of Holdings
0.1%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
5,230
Price
$31.29
Total Value
$163.66K
Shares Held After
4,367
% of Holdings
54.5%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$33.20
Total Value
$67.53K
Shares Held After
231,558
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
15,000
Price
$15.33
Total Value
$229.95K
Shares Held After
198,588
% of Holdings
7.0%
Entrada Therapeutics, Inc. (TRDA)
Sethuraman Natarajan — President, Research & Develop.
Shares
25,907
Price
$15.39
Total Value
$398.81K
Shares Held After
216,317
% of Holdings
10.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.96
Total Value
$138.21K
Shares Held After
18,305
% of Holdings
30.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
47,963
Price
$0.72
Total Value
$34.53K
Shares Held After
1,679,330
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
116
Price
$234.09
Total Value
$27.15K
Shares Held After
41,786
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
105
Price
$232.57
Total Value
$24.42K
Shares Held After
41,902
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
165
Price
$231.87
Total Value
$38.26K
Shares Held After
42,007
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$229.87
Total Value
$229.87
Shares Held After
42,172
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
80
Price
$227.37
Total Value
$18.19K
Shares Held After
42,173
% of Holdings
0.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
7,144
Price
$22.99
Total Value
$164.22K
Shares Held After
32,600
% of Holdings
18.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
5,467
Price
$18.92
Total Value
$103.45K
Shares Held After
600,004
% of Holdings
0.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,795
Price
$6.01
Total Value
$34.83K
Shares Held After
271,774
% of Holdings
2.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,625
Price
$63.48
Total Value
$103.16K
Shares Held After
38,498
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
1,104
Price
$425.02
Total Value
$469.22K
Shares Held After
20,729
% of Holdings
5.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
21,097
Price
$54.04
Total Value
$1.14M
Shares Held After
65,623
% of Holdings
24.3%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
37,327
Price
$53.52
Total Value
$2.00M
Shares Held After
86,720
% of Holdings
30.1%
Showing 801–850 of 1106 transactions (page 17 of 23)